AnnetteWundesMD

PubMed

• Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
  Barry A Singer, Douglas L Arnold, Jelena Drulovic, Mark S Freedman, Ralf Gold, Mark Gudesblatt, Elzbieta Jasinska, Christopher C LaGanke, Robert T Naismith, Donald Neg...> ;Multiple Sclerosis. 2023 Dec 1
• 2 citations
  The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
  Paul Kamudoni, Dagmar Amtmann, Jeffrey Johns, Karon F Cook, Rana Salem, Sam Salek, Jana Raab, Rod Middleton, Pavle Repovic, Kevin N Alschuler, Gloria von Geldern, Anne...> ;Multiple Sclerosis and Related Disorders. 2022 Jun 1
• 12 citations
  Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
  Sibyl Wray, Florian Then Bergh, Annette Wundes, Douglas L Arnold, Jelena Drulovic, Elzbieta Jasinska, James D Bowen, Donald Negroski, Robert T Naismith, Samuel F Hunte...> ;Advances in Therapy. 2022 Apr 1
• Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome
  Kevin N. Alschuler, Daniel Whibley, Anna L. Kratz, Mark P. Jensen, Annette Wundes, Gloria von Geldern, Peiqing Qian, Charles H. Bombardier, Dawn M. Ehde> ;Journal of Neurology. 2021 Oct 19
• 9 citations
  Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a.
  Paul Kamudoni, Jeffrey Johns, Karon F. Cook, Rana Salem, Sam Salek, Jana Raab, Rod Middleton, Christian Henke, Pavle Repovic, Kevin N. Alschuler, Gloria von Geldern, A...> ;Multiple Sclerosis and Related Disorders. 2021 Jun 29
• 1 citations
  Encephalitis and Myelitis in a Young Woman: Overlap Syndrome, Thyroiditis, and Occult Tumor From the National Multiple Sclerosis Society Case Conference Proceedings
  Neda Zarghami Esfanhani, Annette Wundes, Thomas C. Varkey, Robert P. Lisak, Andrew Goodman, Jennifer S. Graves, Scott S. Zamvil, Elliot M. Frohman, Teresa C. Frohman, ...> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2021 Jun 23
• 12 citations
  Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the ran...
  Annette Wundes, Sibyl Wray, Ralf Gold, Barry A Singer, Elzbieta Jasinska, Tjalf Ziemssen, Jérôme De Seze, Pavle Repovic, Hailu Chen, Jerome Hanna, Jordan Messer, Cathe...> ;Therapeutic Advances in Neurological Disorders. 2021 Mar 19
• 4 citations
  Inflammatory colitis associated with Teriflunomide.
  Neda Zarghami Esfahani, Gloria von Geldern, Dhavan A Parikh, Annette Wundes> ;Multiple Sclerosis and Related Disorders. 2020 Nov 1
• 1 citations
  Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS.
  Kevin N. Alschuler, Gloria von Geldern, Darren Ball, Kathleen Costello, Mark B. Skeen, Salim Chahin, Annette Wundes> ;Multiple Sclerosis and Related Disorders. 2020 Nov 1
• 33 citations
  Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study
  Robert T. Naismith, Jerry S. Wolinsky, Annette Wundes, Christopher LaGanke, Douglas L. Arnold, Dragana Obradovic, Mark S. Freedman, Mark Gudesblatt, Tjalf Ziemssen, Bo...> ;Multiple Sclerosis. 2020 Nov 1
• 27 citations
  COVID-19 in MS: Initial observations from the Pacific Northwest.
  James D. Bowen, Justine Brink, Theodore R. Brown, Elisabeth B. Lucassen, Kyle Smoot, Annette Wundes, Pavle Repovic> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2020 Sep 3
• 65 citations
  Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Scleros...
  Robert T. Naismith, Annette Wundes, Tjalf Ziemssen, Elzbieta Jasinska, Mark S. Freedman, Anthony Lembo, Krzysztof Selmaj, Ilda Bidollari, Hailu Chen, Jerome Hanna, Ric...> ;CNS Drugs. 2020 Feb 1
• 6 citations
  Impact of Multiple Sclerosis Project ECHO (Extension for Community Healthcare Outcomes) on Provider Confidence and Clinical Practice.
  Kevin N. Alschuler, Gary Stobbe, Deborah P. Hertz, Kurt L. Johnson, Gloria von Geldern, Annette Wundes, Piper Reynolds, Kent Unruh, John D. Scott> ;International Journal of MS Care. 2019 Aug 23
• 14 citations
  Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort study.
  Lisa G. Gallagher, Sindana D. Ilango, Annette Wundes, Gary Stobbe, Katherine W. Turk, Gary M. Franklin, Martha S. Linet, D. Michal Freedman, Bruce H. Alexander, Harvey...> ;Multiple Sclerosis. 2019 Jul 1
• 5 citations
  FDG-PET abnormalities leading to the diagnosis of an unusual case of probable neurosarcoidosis.
  Yujie Wang, James S. Andrews, Paula Jenkins Colon, Annette Wundes> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2018 Sep 26
• 10 citations
  Improving the quality of depression and pain care in multiple sclerosis using collaborative care: The MS-care trial protocol.
  Dawn M. Ehde, Kevin N. Alschuler, Mark Sullivan, I. Molton, Marcia A. Ciol, Charles H. Bombardier, Mary Curran, Kevin J. Gertz, Annette Wundes, Jesse R. Fann> ;Contemporary Clinical Trials. 2018 Jan 1
• 103 citations
  High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
  Richard A. Nash, George J. Hutton, Michael K. Racke, Uday R. Popat, Steven M. Devine, Kaitlyn C. Steinmiller, Linda M. Griffith, Paolo A. Muraro, Harry Openshaw, Peter...> ;Neurology. 2017 Feb 28
• 3 citations
  Brain pathology of a patient 7 years after autologous hematopoietic stem cell transplantation for multiple sclerosis
  Annette Wundes, James Bowen, George H. Kraft, Kenneth R. Maravilla, Bernadette McLaughlin, Gloria von Geldern, George E. Georges, Richard A. Nash, Jian-Qiang Lu> ;Journal of the Neurological Sciences. 2017 Feb 15
• 26 citations
  Natalizumab-related PML 2 weeks after negative anti-JCV antibody assayAuthor Response
  Daniel Ontaneda, Marie-Sarah Gagne Brosseau, Robert J. Fox, Gary Stobbe, Annette Wundes> ;Neurology. 2016 Aug 30
• 1 citations
  Accelerating international MS care through videoconference-based education and case consultation
  Kevin N. Alschuler, Annette Wundes, Dennis W. Dietrich, Bojan Boskovski, Igor Kuzmanovski, Katharine S. Alexander, Gloria von Geldern, Gary Stobbe> ;Neurology. 2016 Jul 5
• 22 citations
  Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay.
  Marie-Sarah Gagne Brosseau, Gary Stobbe, Annette Wundes> ;Neurology. 2016 Feb 2
• 122 citations
  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.
  Richard A. Nash, George J. Hutton, Michael K. Racke, Uday R. Popat, Steven M. Devine, Linda M. Griffith, Paolo A. Muraro, Harry Openshaw, Peter H. Sayre, Olaf Stüve, D...> ;JAMA Neurology. 2015 Feb 1
• 19 citations
  What do healthcare providers advise women with multiple sclerosis regarding pregnancy
  Annette Wundes, Roxanna N. Pebdani, Dagmar Amtmann> ;Multiple Sclerosis International. 2014 Mar 5
• 59 citations
  Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
  James Bowen, George H. Kraft, Annette Wundes, Qingyan Guan, Kenneth R. Maravilla, Ted Gooley, Peter A. McSweeney, Steven Z. Pavletic, Harry Openshaw, Rainer Storb, Mar...> ;Bone Marrow Transplantation. 2012 Jul 1
• 11 citations
  Mitoxantrone for worsening multiple sclerosis: Tolerability, toxicity, adherence and efficacy in the clinical setting
  Annette Wundes, George H. Kraft, James D. Bowen, Ted Gooley, Richard A. Nash> ;Clinical Neurology and Neurosurgery. 2010 Dec 1
• Join now to see all